ArticleBritish journal of cancer2024

DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity.

Yuechen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.